Acute Decompensated Heart Failure with Severe Left Ventricular Systolic Dysfunction of Undetermined Etiology in a 26-Year-Old Male: A Case Report
Downloads
DOI:
https://doi.org/10.71079/ASIDE.CV.081826789Abstract
Heart failure with reduced ejection fraction HFrEF is rare in young adults but may develop when multiple uncontrolled cardiovascular risk factors are present. The diagnosis of an underlying cause of heart failure among younger patients is difficult due to multiple possible etiologies of LV systolic dysfunction, which might have similar clinical manifestations and imaging features. A 26-year-old man with a past medical history of uncontrolled hypertension and smoking, who came to hospital with complaints of sudden onset of dyspnea and chest pain on the left side, was investigated further to have sinus tachycardia with abnormal R-wave progression on electrocardiogram, cardiomegaly with pulmonary congestion on chest X-ray, and significantly impaired global systolic function of the left ventricle with ejection fraction of 25% on transthoracic echocardiogram. Troponins showed no dynamic change in their rise-and-fall pattern, ruling out acute coronary syndrome. He was stabilized on CPAP breathing and IV nitroglycerine and loop diuretics, with marked relief in symptoms. Following hemodynamic stabilization, guideline-directed medical therapy for HFrEF was initiated. In this case, there is acute decompensated heart failure with reduced ejection fraction (HFrEF) characterized by severe systolic dysfunction occurring in a relatively young individual suffering from numerous risk factors for cardiovascular disorders. The etiology of the condition could not be precisely determined due to the unavailability of coronary angiography and other advanced diagnostic methods. Ischemic cardiomyopathy is just one of the potential causes that also include hypertensive cardiomyopathy, idiopathic dilated cardiomyopathy, toxic cardiomyopathy, and inflammatory cardiomyopathy. The present report highlights the need for careful etiologic assessment of patients presenting with recently developed ventricular dysfunction, appropriate diagnosis in the absence of evidence of coronary disease, and prompt initiation of appropriate therapy
Keywords:
Heart failure with reduced ejection fraction, Undetermined etiology cardiomyopathy, Ischemic cardiomyopathy, Acute pulmonary edema, HypertensionReferences
1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7-11. [PMID: 28785469, https://doi.org/10.15420/cfr.2016:25:2] DOI: https://doi.org/10.15420/cfr.2016:25:2
2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-e621. [PMID: 36695182, https://doi.org/10.1161/CIR.0000000000001123] DOI: https://doi.org/10.1161/CIR.0000000000001137
3. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. [PMID: 34447992, https://doi.org/10.1093/eurheartj/ehab368] DOI: https://doi.org/10.1093/eurheartj/ehab368
4. Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39(2):210-8. [PMID: 11788209, https://doi.org/10.1016/s0735-1097(01)01738-7] DOI: https://doi.org/10.1016/S0735-1097(01)01738-7
5. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97(3):282-9. [PMID: 9462531, https://doi.org/10.1161/01.cir.97.3.282] DOI: https://doi.org/10.1161/01.CIR.97.3.282
6. Sharma SK, Makkar JS, Bana A, et al. Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: hospital-based registry. Indian Heart J. 2022;74(5):391-7. [PMID: 35995321, https://doi.org/10.1016/j.ihj.2022.08.003] DOI: https://doi.org/10.1016/j.ihj.2022.08.003
7. Smith CL, Seigerman M, Adusumalli S, et al. Evolution and outcomes of premature coronary artery disease. Curr Cardiol Rep. 2021;23(4):36. [PMID: 33686513, https://doi.org/10.1007/s11886-021-01457-8] DOI: https://doi.org/10.1007/s11886-021-01457-8
8. Yusuf S, Hawken S, Ounpuu S, INTERHEART Study Investigators, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries: case-control study. Lancet. 2004;364(9438):937-52. [PMID: 15364185, https://doi.org/10.1016/S0140-6736(04)17018-9] DOI: https://doi.org/10.1016/S0140-6736(04)17018-9
9. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53(7):557-73. [PMID: 19215829, https://doi.org/10.1016/j.jacc.2008.10.041] DOI: https://doi.org/10.1016/j.jacc.2008.10.041
10. Milne EN, Pistolesi M, Miniati M, Giuntini C. The radiologic distinction of cardiogenic and noncardiogenic edema. AJR Am J Roentgenol. 1985;144(5):879-94. [PMID: 3872571, https://doi.org/10.2214/ajr.144.5.879] DOI: https://doi.org/10.2214/ajr.144.5.879
11. Lang RM, Bierig M, Devereux RB, American Society of Echocardiography, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. [PMID: 16458610, https://doi.org/10.1016/j.euje.2005.12.014] DOI: https://doi.org/10.1016/j.euje.2005.12.014
12. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure. Circulation. 2017;136(6):e137-61. [PMID: 28455343, https://doi.org/10.1161/CIR.0000000000000509] DOI: https://doi.org/10.1161/CIR.0000000000000509
13. McMurray JJ, Packer M, Desai AS, PARADIGM-HF Investigators, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. [PMID: 25176015, https://doi.org/10.1056/NEJMoa1409077] DOI: https://doi.org/10.1056/NEJMoa1409077
14. Packer M, Anker SD, Butler J, EMPEROR-Reduced Trial Investigators, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-24. [PMID: 32865377, https://doi.org/10.1056/NEJMoa2022190] DOI: https://doi.org/10.1056/NEJMoa2022190
Data Availability Statement
Data are available from the corresponding author on request.
License
Copyright (c) 2026 Abdul Eizad Asif, Ahmad Mustafa Butt, Syed Tahir Hussain, Aqsa Ibrahim, Muhammad Hassaan Javaid

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Licensing
All articles published in ASIDE Cardiovascular are open access and freely available online immediately upon publication, without embargo.
This journal applies the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, anyone may copy, redistribute, remix, transform, and build upon the material for any purpose, even commercially, provided that proper credit is given to the original author(s), a link to the license is provided, and any changes made are indicated.
-
License link: https://creativecommons.org/licenses/by/4.0/
-
Machine-readable license metadata is embedded in each article and its DOI record.
Copyright Holder
Copyright in all articles remains with the author(s). By submitting a manuscript, authors agree to grant the publisher (American Society for Inclusion, Diversity, and Equity in Healthcare – ASIDE) a non-exclusive license to publish and distribute the work under the terms of the CC BY 4.0 license.
Third-party Material
Any material (e.g., images, figures, or tables) not covered by CC BY 4.0 will be clearly indicated in the article. Users must obtain permission directly from the copyright holder for reuse of such third-party material.
Author Rights and Self-Archiving
Authors are permitted to deposit all versions of their work (preprint, author’s accepted manuscript, and version of record) in institutional or subject repositories of their choice immediately upon publication, without embargo, provided that the DOI and license information are included.
Downloads
Published
Issue
Section
How to Cite
Article history
- Received
- 23 Apr 2026
- Received in revised form
- 8 Jun 2026
- Accepted
- 30 Jun 2026
- Published
- 18 Aug 2026